Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women
Clinical trial NCT02568215 · COMPLETED
Trial details
- NCT number
- NCT02568215
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2021-03-03
- Enrollment
- 1924
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.